|
1
|
Zhou TC, Li X, Chen LJ, Fan JH, Lai X,
Tang Y, Zhang L and Wei J: Differential expression profile of
hepatic circular RNAs in chronic hepatitis B. J Viral Hepat.
25:1341–1351. 2018.PubMed/NCBI
|
|
2
|
Sarin SK, Kumar M, Lau GK, Abbas Z, Chan
HL, Chen CJ, Chen DS, Chen HL, Chen PJ, Chien RN, et al:
Asian-Pacific clinical practice guidelines on the management of
hepatitis B: A 2015 update. Hepatol Int. 10:1–98. 2016.
|
|
3
|
Hu J, Cheng J, Tang L, Hu Z, Luo Y, Li Y,
Zhou T, Chang J and Guo JT: Virological basis for the cure of
chronic hepatitis B. ACS Infect Dis. 2018.
|
|
4
|
Yang HC and Kao JH: Persistence of
hepatitis B virus covalently closed circular DNA in hepatocytes:
Molecular mechanisms and clinical significance. Emerg Microbes
Infect. 3:e642014.
|
|
5
|
Zoulim F: New insight on hepatitis B virus
persistence from the study of intrahepatic viral cccDNA. J Hepatol.
42:302–308. 2005.PubMed/NCBI
|
|
6
|
European Association for the Study of the
Liver: EASL clinical practice guidelines: Management of chronic
hepatitis B virus infection. J Hepatol. 57:167–185. 2012.PubMed/NCBI
|
|
7
|
Terrault NA, Bzowej NH, Chang KM, Hwang
JP, Jonas MM and Murad MH; American Association for the Study of
Liver Diseases: AASLD guidelines for treatment of chronic hepatitis
B. Hepatology. 63:261–283. 2016.
|
|
8
|
Lok AS, McMahon BJ, Brown RS Jr, Wong JB,
Ahmed AT, Farah W, Almasri J, Alahdab F, Benkhadra K, Mouchli MA,
et al: Antiviral therapy for chronic hepatitis B viral infection in
adults: A systematic review and meta-analysis. Hepatology.
63:284–306. 2016.
|
|
9
|
European Association for the Study of the
Liver: Electronic address easloffice@easloffice.eu; European
Association for the Study of the Liver: EASL 2017 clinical practice
guidelines on the management of hepatitis B virus infection. J
Hepatol. 67:370–398. 2017.
|
|
10
|
Terrault NA, Lok ASF, McMahon BJ, Chang
KM, Hwang JP, Jonas MM, Brown RS Jr, Bzowej NH and Wong JB: Update
on prevention, diagnosis, and treatment of chronic hepatitis B:
AASLD 2018 hepatitis B guidance. Hepatology. 67:1560–1599.
2018.PubMed/NCBI
|
|
11
|
Tong S and Revill P: Overview of hepatitis
B viral replication and genetic variability. J Hepatol. 64(Suppl
1): S4–S16. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ghany MG: Current treatment guidelines of
chronic hepatitis B: The role of nucleos(t)ide analogues and
peginterferon. Best Pract Res Clin Gastroenterol. 31:299–309. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lai CL, Wong D, Ip P, Kopaniszen M, Seto
WK, Fung J, Huang FY, Lee B, Cullaro G, Chong CK, et al: Reduction
of covalently closed circular DNA with long-term nucleos(t)ide
analogue treatment in chronic hepatitis B. J Hepatol. 66:275–281.
2017. View Article : Google Scholar
|
|
14
|
Nassal M: HBV cccDNA: Viral persistence
reservoir and key obstacle for a cure of chronic hepatitis B. Gut.
64:1972–1984. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tacke F and Kroy DC: Treatment for
hepatitis B in patients with drug resistance. Ann Transl Med.
4:3342016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jiang L, Wu X, He F, Liu Y, Hu X, Takeda S
and Qing Y: Genetic evidence for genotoxic effect of entecavir, an
anti-Hepatitis B virus nucleotide analog. PLoS One.
11:e01474402016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Choi J, Kim HJ, Lee J, Cho S, Ko MJ and
Lim YS: Risk of hepatocellular carcinoma in patients treated with
entecavir vs tenofovir for chronic hepatitis B: A Korean nationwide
cohort study. JAMA Oncol. 5:30–36. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cartus A and Schrenk D: Current methods in
risk assessment of genotoxic chemicals. Food Chem Toxicol.
106:574–582. 2017. View Article : Google Scholar
|
|
19
|
US Food Drug Administration: Draft
guidance on Adefovir Dipivoxil. https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM136541.pdf.
|
|
20
|
Baba TW, Giroir BP and Humphries EH: Cell
lines derived from avian lymphomas exhibit two distinct phenotypes.
Virology. 144:139–151. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bryce SM, Bemis JC, Avlasevich SL and
Dertinger SD: In vitro micronucleus assay scored by flow cytometry
provides a comprehensive evaluation of cytogenetic damage and
cytotoxicity. Mutat Res. 630:78–91. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ellinger-Ziegelbauer H, Fostel JM, Aruga
C, Bauer D, Boitier E, Deng S, Dickinson D, Le Fevre AC, Fornace AJ
Jr, Grenet O, et al: Characterization and interlaboratory
comparison of a gene expression signature for differentiating
genotoxic mechanisms. Toxicol Sci. 110:341–352. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fellows MD and O'Donovan MR: Etoposide,
cadmium chloride, benzo[a]pyrene, cyclophosphamide and colchicine
tested in the in vitro mammalian cell micronucleus test (MNvit) in
the presence and absence of cytokinesis block using L5178Y mouse
lymphoma cells and 2-aminoanthracene tested in MNvit in the absence
of cytokinesis block using TK6 cells at AstraZeneca UK, in support
of OECD draft Test Guideline 487. Mutat Res. 702:163–170. 2010.
View Article : Google Scholar
|
|
24
|
Platel A, Nesslany F, Gervais V and Marzin
D: Study of oxidative DNA damage in TK6 human lymphoblastoid cells
by use of the in vitro micronucleus test: Determination of
no-observed-effect levels. Mutat Res. 678:30–37. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sonoda E, Okada T, Zhao GY, Tateishi S,
Araki K, Yamaizumi M, Yagi T, Verkaik NS, van Gent DC, Takata M and
Takeda S: Multiple roles of Rev3, the catalytic subunit of polzeta
in maintaining genome stability in vertebrates. EMBO J.
22:3188–3197. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Okada T, Sonoda E, Yamashita YM, Koyoshi
S, Tateishi S, Yamaizumi M, Takata M, Ogawa O and Takeda S:
Involvement of vertebrate polkappa in Rad18-independent
postreplication repair of UV damage. J Biol Chem. 277:48690–48695.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Masson M, Niedergang C, Schreiber V,
Muller S, Menissier- de Murcia J and de Murcia G: XRCC1 is
specifically associated with poly(ADP-ribose) polymerase and
negatively regulates its activity following DNA damage. Mol Cell
Biol. 18:3563–3571. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qing Y, Yamazoe M, Hirota K, Dejsuphong D,
Sakai W, Yamamoto KN, Bishop DK, Wu X and Takeda S: The epistatic
relationship between BRCA2 and the other RAD51 mediators in
homologous recombination. PLoS Genet. 7:e10021482011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Takata M, Sasaki MS, Sonoda E, Morrison C,
Hashimoto M, Utsumi H, Yamaguchi-Iwai Y, Shinohara A and Takeda S:
Homologous recombination and non-homologous end-joining pathways of
DNA double-strand break repair have overlapping roles in the
maintenance of chromosomal integrity in vertebrate cells. EMBO J.
17:5497–5508. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rosen EM: BRCA1 in the DNA damage response
and at telomeres. Front Genet. 4:852013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Carmichael J, DeGraff WG, Gazdar AF, Minna
JD and Mitchell JB: Evaluation of a tetrazolium-based semiautomated
colorimetric assay: Assessment of chemosensitivity testing. Cancer
Res. 47:936–942. 1987.PubMed/NCBI
|
|
32
|
Hu X, Wu X, Liu H, Cheng Z, Zhao Z, Xiang
C, Feng X, Takeda S and Qing Y: Genistein-induced DNA damage is
repaired by nonhomologous end joining and homologous recombination
in TK6 cells. J Cell Physiol. 234:2683–2692. 2019. View Article : Google Scholar
|
|
33
|
Mosmann T: Rapid colorimetric assay for
cellular growth and survival: Application to proliferation and
cytotoxicity assays. J Immunol Methods. 65:55–63. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sonoda E, Sasaki MS, Buerstedde JM,
Bezzubova O, Shinohara A, Ogawa H, Takata M, Yamaguchi-Iwai Y and
Takeda S: Rad51-deficient vertebrate cells accumulate chromosomal
breaks prior to cell death. EMBO J. 17:598–608. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
An international system for human
cytogenetic nomenclature 1978 ISCN 1978 Report of the standing
commitee on human cytogenetic nomenclature. Cytogenet Cell Genet.
21:309–409. 1978.
|
|
36
|
Yamamoto KN, Hirota K, Kono K, Takeda S,
Sakamuru S, Xia M, Huang R, Austin CP, Witt KL and Tice RR:
Characterization of environmental chemicals with potential for DNA
damage using isogenic DNA repair-deficient chicken DT40 cell lines.
Environ Mol Mutagen. 52:547–561. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ji K, Kogame T, Choi K, Wang X, Lee J,
Taniguchi Y and Takeda S: A novel approach using
DNA-repair-deficient chicken DT40 cell lines for screening and
characterizing the genotoxicity of environmental contaminants.
Environ Health Perspect. 117:1737–1744. 2009. View Article : Google Scholar
|
|
38
|
Dickey JS, Redon CE, Nakamura AJ, Baird
BJ, Sedelnikova OA and Bonner WM: H2AX: Functional roles and
potential applications. Chromosoma. 118:683–692. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu Y, Wu X, Hu X, Chen Z, Liu H, Takeda S
and Qing Y: Multiple repair pathways mediate cellular tolerance to
resveratrol-induced DNA damage. Toxicol In Vitro. 42:130–138. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ibuki Y and Toyooka T: Evaluation of
chemical phototoxicity, focusing on phosphorylated histone H2AX. J
Radiat Res. 56:220–228. 2015. View Article : Google Scholar :
|
|
41
|
Solovjeva L, Firsanov D, Pleskach N and
Svetlova M: Immunofluorescence analysis of gamma-H2AX Foci in
mammalian fibroblasts at different phases of the cell cycle.
Methods Mol Biol. 1644:187–194. 2017. View Article : Google Scholar
|
|
42
|
Scully R and Livingston DM: In search of
the tumour-suppressor functions of BRCA1 and BRCA2. Nature.
408:429–432. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tarapore P, Hanashiro K and Fukasawa K:
Analysis of centrosome localization of BRCA1 and its activity in
suppressing centrosomal aster formation. Cell Cycle. 11:2931–2946.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Pathania S, Bade S, Le Guillou M, Burke K,
Reed R, Bowman-Colin C, Su Y, Ting DT, Polyak K, Richardson AL, et
al: BRCA1 haploinsufficiency for replication stress suppression in
primary cells. Nat Commun. 5:54962014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Moynahan ME, Chiu JW, Koller BH and Jasin
M: Brca1 controls homology-directed DNA repair. Mol Cell.
4:511–518. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Turner N, Tutt A and Ashworth A: Hallmarks
of ‘BRCAness’ in sporadic cancers. Nat Rev Cancer. 4:814–819. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Prakash R, Zhang Y, Feng W and Jasin M:
Homologous recombination and human health: The roles of BRCA1,
BRCA2, and associated proteins. Cold Spring Harb Perspect Biol.
7:a0166002015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen L, Nievera CJ, Lee AY and Wu X: Cell
cycle-dependent complex formation of BRCA1.CtIP.MRN is important
for DNA double-strand break repair. J Biol Chem. 283:7713–7720.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sartori AA, Lukas C, Coates J, Mistrik M,
Fu S, Bartek J, Baer R, Lukas J and Jackson SP: Human CtIP promotes
DNA end resection. Nature. 450:509–514. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yu X, Wu LC, Bowcock AM, Aronheim A and
Baer R: The C-terminal (BRCT) domains of BRCA1 interact in vivo
with CtIP, a protein implicated in the CtBP pathway of
transcriptional repression. J Biol Chem. 273:25388–25392. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Bunting SF, Callén E, Wong N, Chen HT,
Polato F, Gunn A, Bothmer A, Feldhahn N, Fernandez-Capetillo O, Cao
L, et al: 53BP1 inhibits homologous recombination in
Brca1-deficient cells by blocking resection of DNA breaks. Cell.
141:243–254. 2010. View Article : Google Scholar : PubMed/NCBI
|
